Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
Many of those PI's that invested back in April/May heard CEO's words of 'sales in June' of our covid test when we'd got the Covid test CE approval. Then they were spun the DIVOC and Beckman links later in the summer and shortly after that came South African approval. Now it's 'supporting' Beckman in USA and the Covid POC carrots.
I know, DYOR, but I (and many others) did and based on everything available, this company should have been top of the pile with CE Covid, HCV (WHO prequal'd) and the near future AIHL in their arsenal.
PI's have held believing 'significant' and sizeable sales would naturally follow in what seen as 'target rich' markets, but no, not a bean.
On top of this, since early last summer there's also been the consistent erosion of the PI's value through placings, loan conversions, lack of significant sales in markets that we are approved for and general appalling communication with both PI's and the market in general.
Sure, have a placing but you must get the timing and and pricing right. Sure offer your II's loan conversions too, but this should be done when the sales are strong and you can take your PIs with you too and rather than to their detriment.
My holding has gone from 'x' amount of shares in approx 38million total to 'x' amount of shares in the company of 64million total and with a SP less than 50% of their cost too - not exactly inspiring confidence and trust in the BOD!
The CEO may come across ok in his presentations (if somewhat evasive on sales and approvals) and things may well be going on in the background, but while there's a perception of BOD picking up sizeable salaries and bonuses without returning PI value too, I can fully understand investors being anxious or angry at what seems a dreadfully performing company.
I dunno about a 'Budd express', it's more like Ivor The Engine on the sidings at the moment. Let's hope this gets on the right track soon....
BTW
BP typically has four dividend payments per year i.e one every 3mths.
Other companies may make dividend payments once or twice a year. However, not all companies pay a dividend.
Try here, it may help you...
https://www.investopedia.com/terms/d/dividend.asp
Helpful site for other info on the too.
I don't believe that's our kit in that particular article....
"At the first stage of the laboratory's power center, there are 30,000 PCR tests per month . Also in the near future, the company is preparing to launch testing on automatic equipment company Abbott (USA), which will increase the capacity of the laboratory to 100 thousand PCR tests per month.
According to Butenko, at the first stage of PCR testing on COVID-19 will be performed on reagents from BAG Diagnostics (Germany) . The test systems have undergone clinical trials and are EU accredited. Leading laboratories in Europe use similar reagents for population testing.
From November, Sinevo plans to launch testing on automatic equipment and reagents from Abbott (USA) , which is considered one of the top manufacturers of equipment and reagents in the field of laboratory diagnostics in the world."
That's not to say our kit isn't elsewhere in the country tho'....
Unfortunately, 'imagine' is all we can do!
More dilution to existing PI's and if the block is sold into any 'good' news no doubt it will hold back SP potential maximum growth.......
That Golden Goose better come a'laying!!
I really have been keeping the faith here but I'm starting to feel more like a martyr than an invester!!
I believe we are now seeing the punishment effect of a summer of placings, conversions, dilutions and large ii sells without the benefit of any significant new sales news whatsoever.
No point having low or no debt with cash in the bank if your stock is dying on its feet eh?
If approvals are taking a long time, I can't fathom why you wouldn't seek orders from the markets you are approved for - CE zones and South Africa?
Or maybe we have, but Secret Squirrel isn't saying???
Even the AIHL Genedrive kit sales aren't starting until months after the the expected Jan release of the report for such a successful trial. Launch and strike while it's hot news I say!
Clever with imaginative scientific and engineering solutions GDR may be, but sales seem a bit of a sticky wicket or maybe I just don't understand...
Let's just pray and hope Covid Spitty POC is our Golden Goose....please Santa....
Could that Tweet registration snippet be for our DOD work rather than Covid?
The AIHL trial (@PALOH_Study) seems have gone well. Posted by John McDermott (lead on the AIHL trial?) on Twitter yesterday (30th Nov).
"Today is the final day of the @PALOH_Study!
It's been a huge achievement to recruit over 750 babies at @MFT_SMH despite COVID disruption."
"I'm incredibly proud to have been part of this study which brought together clinicians, academics and industry from across @OfficialUoM, @MFT_Genomics, @MFT_SMH and @genedriveplc"
"From tomorrow we'll start to look at the data, hoping to publish early in the new year.
Specifically, we'll explore whether genetic technology such as this can be implemented successfully in the acute setting, without disrupting normal standard of care."
So it looks like H1 2021 launch is still on for what should eventually be a good longterm global seller for GDR!
Success and increased revenue should drive new products and further growth which all should hopefully be reflected in the MCap :)
Long time lurker, first time poster.
Am I correct in understanding is that the infant AIHL MT-RNR1 assay trial is coming to an end next week?
Would have thought pricing etc. would have already been worked out by now, so does anybody have any idea about what happens next and what (if anything) needs to be done prior to its launch with Inspiration Healthcare and being able to sell it to countries that accept the CE mark qualification?
I am hoping that any further territory qualification applications e.g. FDA, WHO etc., will not hold up the initial launch to CE markets!
Surely this has got to be GDR's 'easiest' seller, especially linking up with IHC, specialist distributors to the target market - I mean, why wouldn't every maternity/pediatric unit have one??